China Jo Jo Drugstores Stock Cash And Equivalents
| CJJD Stock | USD 2.01 0.02 0.99% |
China Jo Jo Drugstores fundamentals help investors to digest information that contributes to China Jo's financial success or failures. It also enables traders to predict the movement of China Stock. The fundamental analysis module provides a way to measure China Jo's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China Jo stock.
China | Cash And Equivalents |
China Jo Jo Drugstores Company Cash And Equivalents Analysis
China Jo's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current China Jo Cash And Equivalents | 18.55 M |
Most of China Jo's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China Jo Jo Drugstores is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
China Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for China Jo is extremely important. It helps to project a fair market value of China Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since China Jo's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of China Jo's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of China Jo's interrelated accounts and indicators.
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
China Cash And Cash Equivalents Changes
Cash And Cash Equivalents Changes |
|
In accordance with the recently published financial statements, China Jo Jo Drugstores has 18.55 M in Cash And Equivalents. This is 97.74% lower than that of the Consumer Staples Distribution & Retail sector and significantly higher than that of the Consumer Staples industry. The cash and equivalents for all United States stocks is 99.31% higher than that of the company.
China Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Jo's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of China Jo could also be used in its relative valuation, which is a method of valuing China Jo by comparing valuation metrics of similar companies.China Jo is currently under evaluation in cash and equivalents category among its peers.
China Jo Current Valuation Drivers
We derive many important indicators used in calculating different scores of China Jo from analyzing China Jo's financial statements. These drivers represent accounts that assess China Jo's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of China Jo's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 59.4M | 45.7M | 1.1M | 45.7M | 4.7M | 630.0K | |
| Enterprise Value | 97.7M | 70.4M | 31.3M | 69.0M | 27.7M | 628.4K |
China Jo ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, China Jo's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to China Jo's managers, analysts, and investors.Environmental | Governance | Social |
China Fundamentals
| Return On Equity | -0.27 | ||||
| Return On Asset | -0.0238 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0.05) % | ||||
| Current Valuation | 35.51 M | ||||
| Shares Outstanding | 6.18 M | ||||
| Shares Owned By Insiders | 38.34 % | ||||
| Shares Owned By Institutions | 0.31 % | ||||
| Number Of Shares Shorted | 30.24 K | ||||
| Price To Earning | (4.60) X | ||||
| Price To Book | 0.80 X | ||||
| Price To Sales | 0.08 X | ||||
| Revenue | 154.54 M | ||||
| Gross Profit | 34.28 M | ||||
| EBITDA | 1.23 M | ||||
| Net Income | (4.23 M) | ||||
| Cash And Equivalents | 18.55 M | ||||
| Cash Per Share | 5.33 X | ||||
| Total Debt | 43.22 M | ||||
| Debt To Equity | 2.14 % | ||||
| Current Ratio | 1.01 X | ||||
| Book Value Per Share | 8.97 X | ||||
| Cash Flow From Operations | (3.16 M) | ||||
| Short Ratio | 2.29 X | ||||
| Earnings Per Share | (2.93) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 939 | ||||
| Beta | -0.043 | ||||
| Market Capitalization | 12.54 M | ||||
| Total Asset | 95.06 M | ||||
| Retained Earnings | (73.51 M) | ||||
| Working Capital | (4.68 M) | ||||
| Current Asset | 46.88 M | ||||
| Current Liabilities | 42.12 M | ||||
| Net Asset | 95.06 M |
About China Jo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Jo Jo Drugstores's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Jo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Jo Jo Drugstores based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether China Jo Jo is a strong investment it is important to analyze China Jo's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact China Jo's future performance. For an informed investment choice regarding China Stock, refer to the following important reports:Check out China Jo Piotroski F Score and China Jo Altman Z Score analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Jo. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Jo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.93) | Revenue Per Share 107.003 | Quarterly Revenue Growth (0) | Return On Assets (0.02) | Return On Equity (0.27) |
The market value of China Jo Jo is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Jo's value that differs from its market value or its book value, called intrinsic value, which is China Jo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Jo's market value can be influenced by many factors that don't directly affect China Jo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Jo's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Jo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Jo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.